/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

C

Chihiro Shiraishi

Fukuoka University(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

47

Papers

119

Citations

6

h-index

4

i10-index

Chihiro Shiraishi is an academic researcher from Fukuoka University. The author has contributed to research in topics: Pharmacological Effects and Toxicity Studies & PARP inhibition in cancer therapy & Pharmacovigilance and Adverse Drug Reactions. The author has an h-index of 6, co-authored 40 publications.

ORCID: 0000-0002-1190-6540

Research Topics

Pharmacological Effects and Toxicity Studies PARP inhibition in cancer therapy Pharmacovigilance and Adverse Drug Reactions Renal Transplantation Outcomes and Treatments Antibiotics Pharmacokinetics and Efficacy

Papers by this author

works

Comparison of clinical efficacy and safety of baloxavir marboxil versus oseltamivir as the treatment for influenza virus infections: A systematic review and meta-analysis

2023 · Journal of Infection and Chemotherapy · 21 citations

https://doi.org/10.1016/j.jiac.2023.10.017

Chihiro Shiraishi Hideo Kato Mao Hagihara Nobuhiro Asai

Association between voriconazole-induced visual hallucination and dopamine in an analysis of the food and drug administration (FDA) adverse event reporting system database

2024 · Scientific Reports · 8 citations

https://doi.org/10.1038/s41598-024-63504-y

Hideo Kato Chihiro Shiraishi Mao Hagihara Hiroshige Mikamo

Factors affecting serum phenobarbital concentration changes in pediatric patients receiving elixir and powder formulations

2021 · Journal of Pharmaceutical Health Care and Sciences · 4 citations

https://doi.org/10.1186/s40780-021-00190-2

Chihiro Shiraishi Hiroko Matsuda Toru Ogura Takuya Iwamoto

Comparative Analysis of Adverse Event Profiles Among Seven Statins for Hypercholesterolemia Management Using the United States FDA Adverse Event Reporting System

2025 · Cureus · 2 citations

https://doi.org/10.7759/cureus.81260

Toru Ogura Chihiro Shiraishi

Comparison of Adverse Events Following Immunosuppressant Administration for Pediatric Patients With Renal Transplants Categorized by Two-Year Age Increments Using the U.S. Food and Drug Administration Adverse Event Reporting System

2024 · Cureus · 1 citations

https://doi.org/10.7759/cureus.65300

Toru Ogura Chihiro Shiraishi Yuko Tamura Aiko Urawa

Effect of Clostridium butyricum and antibiotics using simultaneous simple suspension in mice with Clostridioides difficile infection

2025 · Experimental and Molecular Pathology · 0 citations

https://doi.org/10.1016/j.yexmp.2025.104979

Hideo Kato Mao Hagihara Chihiro Shiraishi Yuki Asai

Research topics

topics

Pharmacological Effects and Toxicity Studies

PARP inhibition in cancer therapy

Pharmacovigilance and Adverse Drug Reactions

Renal Transplantation Outcomes and Treatments

Antibiotics Pharmacokinetics and Efficacy

Chat about Author

Papers

Chat

Click to start Chat